Genvoya is an antiviral medicine used to treat individuals infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). It is used in adults and children from 2 years of age and weighing at least 14 kg whose disease is not expected to be resistant to any of the antiviral substances in Genvoya. Genvoya contains the active substances elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide.
Therapeutic Indication
### Therapeutic indication Genvoya is indicated for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus 1 (HIV 1) without any known mutations associated with resistance to the integrase inhibitor class, emtricitabine or tenofovir.
Therapeutic Area (MeSH)
ATC Code
J05AR
ATC Item
治疗HIV感染的抗病毒药, 复方
Pharmacotherapeutic Group
Antivirals for systemic use
Active Substance (Summary)
INN / Common Names
EMA Name
Genvoya
Medicine Name
Genvoya
Aliases
N/ANo risk management plan link.
